ÂÜÀòÂÒÂ×

Mr. Roy has served as President & CEO of VetDC since 2010. Previously, he served as Director of Licensing at Amgen, Inc. (NASDAQ – AMGN, an international biopharmaceutical company) where he played roles in Business Development, Marketing and Licensing from 1994 to 2007. Mr. Roy headed up Strategy, Planning and Operations for the launch of a multi-billion dollar cancer therapeutic and created and led Amgen’s Department of Alliance Management, representing 70 collaborations and over $100M in annual R&D expenditure. Mr. Roy began his career as a Laboratory Supervisor at Ligand Pharmaceuticals, Inc. (NASDAQ – LGND) from 1988 to 1992 where he implemented Ligand’s high-throughput screening program. Steven earned a BA in Molecular Biology from the University of California, San Diego and an MBA from the University of Michigan.